Superworth

Phathom Pharmaceuticals EPS PHAT

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
−$1.28
Latest quarter, Q2 FY26
−$0.21
Fiscal year 2025
−$3.06

Phathom Pharmaceuticals' earnings per share was −$1.28 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.21.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.06n/a
FY2024−$5.35n/a
FY2023−$3.88n/a
FY2022−$5.05n/a
FY2021−$3.89n/a
FY2020−$3.86n/a
FY2019−$26.57n/a
FY2018−$0.22n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.21n/a−$1.28
Q1 FY26−$0.37n/a−$2.12
Q4 FY25−$0.29n/a−$3.06
Q3 FY25−$0.41n/a−$3.82
Q2 FY25−$1.05n/a−$4.73
Q1 FY25−$1.31n/a−$5.24
Q4 FY24−$1.05n/a−$5.35
Q3 FY24−$1.32n/a−$5.69
Q2 FY24−$1.56n/a−$5.13
Q1 FY24−$1.42n/a−$4.41
Q4 FY23−$1.39n/a−$3.88
Q3 FY23−$0.76n/a−$3.82

Against its peers

Companies in Drug Manufacturers - General nearest Phathom Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
PHATPhathom Pharmaceuticals−$1.28
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
NATRNatures Sunshine Products$1.01+36% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Phathom Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.